GARY B BELL

Allopathic & Osteopathic Physicians|Internal Medicine COLUMBIA, SC NPI 1689640922

General Payments — all program years on this page

$1,245.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $271.80 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $271.8015

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $101.256
PFIZER INC. $37.502
ABBVIE INC. $36.102
Acerta Pharma LLC $32.822
Amgen Inc. $23.551
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.461
Novo Nordisk AS $17.121

By program year

Program yearAmountRecords
2018 $26.632
2022 $364.7423
2023 $581.8735
2024 $271.8015

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096636805 Novo Nordisk Inc $17.12 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103303164 ABBVIE INC. $17.50 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103303166 ABBVIE INC. $18.60 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105609297 AstraZeneca Pharmaceuticals LP $17.51 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105823051 AstraZeneca Pharmaceuticals LP $15.31 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117201191 Amgen Inc. $23.55 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132058380 PFIZER INC. $17.20 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132059494 PFIZER INC. $20.30 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134982662 Lilly USA, LLC $15.95 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134983400 Lilly USA, LLC $22.99 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134984976 Lilly USA, LLC $13.89 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134994976 Lilly USA, LLC $16.56 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135000596 Lilly USA, LLC $15.45 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135000598 Lilly USA, LLC $16.41 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153704814 Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.46 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.